Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPLENEVAC: Pneumococcal Vaccination Strategy in Splenectomized Adults
NCT02052154Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2014
- Primary completion
- Jul 2016
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of pneumococcal 13-valent conjugate vaccine, Pneumo 23 in pneumococcal infection, sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2014; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccinePneumo 23
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02052154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052154.